BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26522064)

  • 21. Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years.
    Northcott PA; Rutka JT; Taylor MD
    Neurosurg Focus; 2010 Jan; 28(1):E6. PubMed ID: 20043721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and future molecular profiling of cancer by next-generation sequencing.
    Shibata T
    Jpn J Clin Oncol; 2015 Oct; 45(10):895-9. PubMed ID: 26292697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studying cancer genomics through next-generation DNA sequencing and bioinformatics.
    Doyle MA; Li J; Doig K; Fellowes A; Wong SQ
    Methods Mol Biol; 2014; 1168():83-98. PubMed ID: 24870132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?].
    Leichsenring J; Kazdal D; Ploeger C; Allgäuer M; Endris V; Volckmar AL; Neumann O; Kirchner M; Penzel R; Rempel E; Budczies J; Schirmacher P; Fröhling S; Stenzinger A
    Pathologe; 2019 May; 40(3):235-242. PubMed ID: 31089797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The variation game: Cracking complex genetic disorders with NGS and omics data.
    Cui H; Dhroso A; Johnson N; Korkin D
    Methods; 2015 Jun; 79-80():18-31. PubMed ID: 25944472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
    Friedman K; Resnick MB; Safran H
    R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation sequencing technologies for DNA methylation analyses in cancer genomics.
    Boerno ST; Grimm C; Lehrach H; Schweiger MR
    Epigenomics; 2010 Apr; 2(2):199-207. PubMed ID: 22121870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of new high-throughput technologies for diagnosis and prognosis in solid tumors.
    Pinto R; De Summa S; Petriella D; Tudoran O; Danza K; Tommasi S
    Cancer Biomark; 2014; 14(2-3):103-17. PubMed ID: 24878811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updates in Tumor Profiling in Gastrointestinal Cancers.
    Perez K; Safran HP
    R I Med J (2013); 2015 Oct; 98(10):21-4. PubMed ID: 26422541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide analysis of microRNA and mRNA expression signatures in cancer.
    Li MH; Fu SB; Xiao HS
    Acta Pharmacol Sin; 2015 Oct; 36(10):1200-11. PubMed ID: 26299954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep sequencing in cancer research.
    Yoshida K; Sanada M; Ogawa S
    Jpn J Clin Oncol; 2013 Feb; 43(2):110-5. PubMed ID: 23225907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges.
    Liu B; Morrison CD; Johnson CS; Trump DL; Qin M; Conroy JC; Wang J; Liu S
    Oncotarget; 2013 Nov; 4(11):1868-81. PubMed ID: 24240121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomics of Alzheimer's disease: Value of high-throughput genomic technologies to dissect its etiology.
    Tosto G; Reitz C
    Mol Cell Probes; 2016 Dec; 30(6):397-403. PubMed ID: 27618776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
    Patel LR; Nykter M; Chen K; Zhang W
    Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis.
    Mardis E; Raison C
    Expert Rev Mol Diagn; 2015 Apr; 15(4):449-50. PubMed ID: 25795041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.
    Sabour L; Sabour M; Ghorbian S
    Pathol Oncol Res; 2017 Apr; 23(2):225-234. PubMed ID: 27722982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatics Data Analysis of Next-Generation Sequencing Data from Heterogeneous Tumor Samples.
    Landman SR; Hwang TH
    Methods Mol Biol; 2017; 1633():185-192. PubMed ID: 28735488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.